Clinical Trial Update: Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Renal Impairment [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the pharmacokinetics and safety of VX-548 in participants with renal impairment and has completed. The trial assessed PK parameters an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• VX-548

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Pain | Phase 1 | Status: COMPLETED